|
Phospholipid and Sphingolipid Signaling in Drosophila
|
Z01 BC 010331
|
$523,585
|
Acharya, Jairaj
|
CCR (NCI)
|
|
Mechanisms in Perinatal Carcinogenesis
|
Z01 BC 005352
|
$286,829
|
Anderson, Lucy
|
CCR (NCI)
|
|
Protooncogenes-Signaling in Development and Neoplasia
|
5P01CA023767-28
|
$1,066,134
|
AXEL, RICHARD
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Drug Development and Clinical Pharmacology of Anticancer Drugs for Childhood Canc
|
Z01 SC 006880
|
$1,453,500
|
Balis, Frank
|
CCR (NCI)
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA006516-43S1
|
$124,531
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA006516-43S3
|
$137,869
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA006516-43S4
|
$232,326
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA006516-43S5
|
$250,000
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
CANCER CENTER SUPPORT GRANT
|
5P30CA006516-43
|
$11,526,509
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
Matrix Metalloproteinases Gordon Conference
|
5R13CA115182-02
|
$5,000
|
BLOBEL, CARL
|
GORDON RESEARCH CONFERENCES
|
|
Molecular Mechanism of Action of Phorbol Ester
|
Z01 BC 005270
|
$1,250,284
|
Blumberg, Peter
|
CCR (NCI)
|
|
Molecular profiling of patients undergoing radiotherapy
|
Z01 SC 010372
|
$435,626
|
Camphausen, Kevin
|
CCR (NCI)
|
|
The synergy between radiotherapy and molecularly targeted agents
|
Z01 SC 010373
|
$435,626
|
Camphausen, Kevin
|
CCR (NCI)
|
|
Combination of Radiation with Multi-Target Molecular Therapy for Cancer
|
Z01 BC 010658
|
$237,135
|
Capala, Jacek
|
CCR (NCI)
|
|
Regulating Neuroendocrine Phenotype in Cancer
|
5R01CA109053-02
|
$202,687
|
CHEN, HERBERT
|
UNIVERSITY OF WISCONSIN MADISON
|
|
Elucidating the role of the mTOR pathway in NF1-related tumorigenesis
|
1R01CA129814-01
|
$302,105
|
CICHOWSKI, KAREN
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Dynamic Regulation of Ras via the NF1 tumor Suppressor
|
5R01CA111754-03
|
$280,637
|
CICHOWSKI, KAREN
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Developmental Signal Transduction in Xenopus Oocytes and Embryos
|
Z01 BC 010006
|
$689,247
|
Daar, Ira
|
CCR (NCI)
|
|
Neuronal Cell Death Regulation in Drosophila
|
Z01 BC 010275
|
$640,691
|
Davidson, Florence
|
CCR (NCI)
|
|
Identification of Single Nucleotide Polymorphisms in Cancer-Related Genes
|
Z01 BC 005652
|
$505,750
|
Dean, Michael
|
CCR (NCI)
|
|
Clinical Pharmacogenetics
|
Z01 BC 010627
|
$102,568
|
Figg, William
|
CCR (NCI)
|
|
Exploration of the Translational/Therapeutic Potential of Stem Cell B
|
Z01 BC 010839
|
$1,611,664
|
Fine, Howard
|
CCR (NCI)
|
|
Molecular and Genetic Characterization of Human Gliomas to Identify New Targets
|
Z01 SC 010100
|
$1,564,262
|
Fine, Howard
|
CCR (NCI)
|
|
High Throughput MR Microscopy for Cancer Screening
|
1R43CA130870-01
|
$99,998
|
Forbes, Bryn
|
MRPATH, INC.
|
|
Regulated proteolysis in developmental signaling
|
Z01 BC 010529
|
$586,170
|
Fortini, Mark
|
CCR (NCI)
|
|
Connecting PTEN and NF2 cancer predisposition syndromes
|
5R01CA107201-03
|
$254,494
|
GEORGESCU, MARIA-MAGDALENA
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
Modeling of the structure and functional mechanisms of voltage-gated channels
|
Z01 BC 010721
|
$183,149
|
Guy, H. Robert
|
CCR (NCI)
|
|
Regulation of Melanocyte Development and Differentiation
|
Z01 BC 010479
|
$69,502
|
Hornyak, Thomas
|
CCR (NCI)
|
|
Id2 in cell cycle regulation and cancer
|
5R01CA085628-08
|
$361,563
|
IAVARONE, ANTONIO
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Cancer Center Support (Core) Grant
|
5P30CA014051-36
|
$2,815,899
|
JACKS, TYLER
|
MASSACHUSETTS INSTITUTE OF TECHNOLOGY
|
|
Anatomic Pathology Residency Program
|
Z01 BC 010684
|
$1,395,646
|
Jaffe, Elaine
|
CCR (NCI)
|
|
Regulation of EGFR Gene Activity
|
Z01 BC 008000
|
$87,225
|
Johnson, Alfred
|
CCR (NCI)
|
|
Diazeniumdiolate Chemistry as a Platform for Designing Nitric Oxide-Based Therapi
|
Z01 BC 005673
|
$776,194
|
Keefer, Larry
|
CCR (NCI)
|
|
Ras-mediated signals in human epithelial cell transformation and metastasis
|
Z01 BC 010607
|
$211,656
|
Kelly, Kathleen
|
CCR (NCI)
|
|
In Vivo MRI imaging of single metastatic cells
|
Z01 BC 010731
|
$105,828
|
Kelly, Kathleen
|
CCR (NCI)
|
|
The Drosophilia Lgl tumor model as a functional screen for metastasis genes
|
Z01 BC 010732
|
$35,276
|
Kelly, Kathleen
|
CCR (NCI)
|
|
Comparative Genomic Hybridization of Neuroblastoma
|
Z01 BC 010592
|
$175,175
|
Khan, Javed
|
CCR (NCI)
|
|
Identification of Genes for Predicting Prognosis in Pediatric Cancers
|
Z01 SC 010366
|
$218,969
|
Khan, Javed
|
CCR (NCI)
|
|
Postmortem Pathology
|
Z01 BC 010685
|
$236,214
|
Kleiner, David
|
CCR (NCI)
|
|
Tissue Microarray Design and Development for Novel Gene and Gene Product Screenin
|
Z01 SC 010364
|
$515,375
|
Kleiner, David
|
CCR (NCI)
|
|
DNA Repair in Human Cancer-Prone Genetic Diseases
|
Z01 BC 004517
|
$864,697
|
Kraemer, Kenneth
|
CCR (NCI)
|
|
Development of Recombinant Toxins for Treatment of Patients with Hematologic Mali
|
Z01 BC 010301
|
$405,903
|
Kreitman, Robert
|
CCR (NCI)
|
|
The Nodal Signaling Pathway In Embryonic Development
|
Z01 BC 010256
|
$391,518
|
Kuehn, Michael
|
CCR (NCI)
|
|
MLK3 function in neurofibromatosis tumor cells
|
5R01CA112399-03
|
$244,195
|
Kyriakis, John
|
NEW ENGLAND MEDICAL CENTER HOSPITALS
|
|
Progestin and growth factor cross-talk in breast cancer
|
5R01CA123763-11
|
$228,392
|
LANGE, CAROL
|
UNIVERSITY OF MINNESOTA TWIN CITIES
|
|
Using Zebrafish to Identify and Analyze Cancer Genes
|
5R01CA106416-02
|
$352,606
|
Lees, Jacqueline
|
MASSACHUSETTS INSTITUTE OF TECHNOLOGY
|
|
The Role of Fgf Signaling in Vertebrate Development
|
Z01 BC 010338
|
$210,190
|
Lewandoski, Mark
|
CCR (NCI)
|
|
Studies of Proteins with Important Roles in Immunology and/or Cancer Biology
|
Z01 BC 010761
|
$77,793
|
Lubkowski, Jacek
|
CCR (NCI)
|
|
Immunobiology and Immunotherapy of Pediatric Tumors
|
Z01 SC 010289
|
$548,542
|
Mackall, Crystal
|
CCR (NCI)
|
|
Molecular Function of the Nf2 Tumor Suppressor, Merlin
|
5R01CA113733-03
|
$226,284
|
MCCLATCHEY, ANDREA
|
MASSACHUSETTS GENERAL HOSPITAL
|
Relevant funding data is only available when one cancer type or one research topic is selected.
|